Skip to main content

Estradiol and Norethindrone Acetate 1 mg/1 / .5 mg/1 Medicare Part D Coverage

Brand name: Mimvey
Dosage form
TABLET, FILM COATED
Route
ORAL
71%
of Medicare Part D plans
cover Estradiol and Norethindrone Acetate
3,910 of 5,530 plans
3.0
Avg. formulary tier
$15.00
Median 30-day copay
$0.00–$30.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify Estradiol and Norethindrone Acetate. Lower tiers = lower copays.

Tier 1 - Preferred Generic 4%
145 plans • avg $0.00/mo
Tier 2 - Generic 30%
1,156 plans • avg $0.40/mo
Tier 3 - Preferred Brand 26%
1,004 plans • avg $2.53/mo
Tier 4 - Non-Preferred Drug 41%
1,605 plans • avg $18.68/mo

Find the cheapest plan for Estradiol and Norethindrone Acetate

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for Estradiol and Norethindrone Acetate →

Get Estradiol and Norethindrone Acetate Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

Estradiol and Norethindrone Acetate Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about Estradiol and Norethindrone Acetate

71% of Medicare Part D plans cover Estradiol and Norethindrone Acetate. It is most commonly placed on Tier 3. Coverage varies by plan and geographic area.

The median 30-day copay for Estradiol and Norethindrone Acetate on Medicare Part D is $15.00 at a preferred pharmacy. Costs range from $0.00 to $30.00 depending on the plan.

Estradiol and Norethindrone Acetate is placed on Tier 3 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for Estradiol and Norethindrone Acetate. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →